ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,363.36
1.81%
US Tech 100
18,164.80
1.78%
다우존스 지수
40,212.71
1.56%
Bitcoin
84,522.37
0.99%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Enlivex Therapeutics Ltd (ENLV) 시세

Enlivex Therapeutics Ltd

Enlivex Therapeutics Ltd (ENLV)

NASDAQ
0.8975
-0.0225
(-2.45%)
마감 14 4월 5:00AM
15분 지연
0.899899
0.0024
(0.27%)
시간외 거래: 8:59AM
15분 지연

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

주요 통계 및 세부정보

가격
0.8975
매수가
0.90
매도가
0.96
거래량
36,171
0.861 일간 변동폭 0.92
0.8101 52주 범위 2.24
market_cap
18.74M
전일 종가
0.92
개장가
0.92
최근 거래 시간
100
@
0.8975
마지막 거래 시간
재정 규모
US$ 32,537
VWAP
0.899528
평균 볼륨(3m)
133,729
발행 주식
20,880,000
배당수익률
-
주가수익률
-0.65
주당순이익(EPS)
-1.39
매출
-
순이익
-29.07M

Enlivex Therapeutics Ltd 정보

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threate... Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.enlivex.com
본부
Ness Ziona, Center, Isr
설립됨
-
Enlivex Therapeutics Ltd is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker ENLV. The last closing price for Enlivex Therapeutics was US$0.92. Over the last year, Enlivex Therapeutics shares have traded in a share price range of US$ 0.8101 to US$ 2.24.

Enlivex Therapeutics currently has 20,880,000 shares in issue. The market capitalisation of Enlivex Therapeutics is US$19.21 million. Enlivex Therapeutics has a price to earnings ratio (PE ratio) of -0.65.

ENLV 최신 뉴스

추가 뉴스

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
03 4월 2025
ENLV (-2.45%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
01 4월 2025
ENLV (-2.45%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
17 3월 2025
ENLV (-2.45%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
05 3월 2025
ENLV (-2.45%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
03 3월 2025
ENLV (-2.45%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.0225-2.445652173910.920.940.85784960.90344137CS
4-0.2425-21.27192982461.141.290.851025431.04663862CS
12-0.2625-22.62931034481.161.290.851337291.07690567CS
26-0.5725-38.94557823131.471.74970.81011901041.2010988CS
52-1.3125-59.38914027152.212.240.81011532091.32843835CS
156-7.0525-88.71069182397.9580.8101832632.22826067CS
260-3.6625-80.31798245614.5629.40.81011730628.64773203CS

ENLV - Frequently Asked Questions (FAQ)

What is the current Enlivex Therapeutics share price?
The current share price of Enlivex Therapeutics is US$ 0.8975
How many Enlivex Therapeutics shares are in issue?
Enlivex Therapeutics has 20,880,000 shares in issue
What is the market cap of Enlivex Therapeutics?
The market capitalisation of Enlivex Therapeutics is USD 19.21M
What is the 1 year trading range for Enlivex Therapeutics share price?
Enlivex Therapeutics has traded in the range of US$ 0.8101 to US$ 2.24 during the past year
What is the PE ratio of Enlivex Therapeutics?
The price to earnings ratio of Enlivex Therapeutics is -0.65
What is the reporting currency for Enlivex Therapeutics?
Enlivex Therapeutics reports financial results in USD
What is the latest annual profit for Enlivex Therapeutics?
The latest annual profit of Enlivex Therapeutics is USD -29.07M
What is the registered address of Enlivex Therapeutics?
The registered address for Enlivex Therapeutics is 14 EINSTEIN STREET, NESS ZIONA, CENTER, 7403618
What is the Enlivex Therapeutics website address?
The website address for Enlivex Therapeutics is www.enlivex.com
Which industry sector does Enlivex Therapeutics operate in?
Enlivex Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
MSPRMSP Recovery Inc
US$ 2.479
(93.67%)
85.68M
PRTGPortage Biotech Inc
US$ 8.5091
(66.85%)
29.09M
WTOUTime Limited
US$ 2.15
(61.65%)
1.19M
BFRGBullfrog AI Holdings Inc
US$ 2.09
(48.23%)
13.75M
THTXTheratechnologies Inc
US$ 1.94
(45.86%)
48.09M
TOROVToro Corporation
US$ 1.43
(-82.48%)
109.39k
LUCYInnovative Eyewear Inc
US$ 2.3471
(-52.58%)
1.98M
XHGXChange TED Inc
US$ 0.1985
(-45.71%)
8.7M
MULNMullen Automotive Inc
US$ 2.18
(-39.44%)
4.35M
FLDFold Holdings Inc
US$ 2.6601
(-33.50%)
1.74M
DMNDamon Inc
US$ 0.003
(-28.57%)
1.08B
BONBon Natural Life Ltd
US$ 0.066
(8.73%)
658M
STSSSharps Technology Inc
US$ 0.0245
(33.88%)
653.02M
NVDANVIDIA Corporation
US$ 110.93
(3.12%)
313.46M
LGMKLogicMark Inc
US$ 0.009699
(3.18%)
264.71M

ENLV Discussion

게시물 보기
Monksdream Monksdream 1 월 전
ENLV under $2
👍️0
redspinelpinktopaz redspinelpinktopaz 4 월 전
They're advertising on CNBC. What's that all about?
👍️0
glenn1919 glenn1919 4 월 전
enlv...................................https://stockcharts.com/h-sc/ui?s=ENLV&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 7 월 전
ENLV.........................................https://stockcharts.com/h-sc/ui?s=ENLV&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 1 년 전
ENLV under $4
👍️0
TrendTrade2016 TrendTrade2016 1 년 전
ENLV...NEXT BIO BEAST READY TO break out
👍️0
MOCKBA MOCKBA 6 년 전
I see ok, they should send a PR about it!
👍️0
dinogreeves dinogreeves 6 년 전
I mean that ENLV is now Nasdaq compliant, there are no issues with Nasdaq on their filings,
👍️0
MOCKBA MOCKBA 6 년 전
What you mean by that?
👍️0
dinogreeves dinogreeves 6 년 전
ENLV Nasdaq compliant now, should get a press release soon.
👍️0
dinogreeves dinogreeves 6 년 전
checkout website you'll be impressed

https://www.enlivex.com
👍️0
MOCKBA MOCKBA 6 년 전
Dino, grabbed a small position, looks very intriguing to say the least
👍️0
dinogreeves dinogreeves 6 년 전
They have over 35 million in cash man, no dilution for at least 2 years. Buy ENLV with everything you got.
👍️0
dinogreeves dinogreeves 6 년 전
This is ENLV now, buy all you can, they reverse merged with ORPN
👍️0
dinogreeves dinogreeves 6 년 전
This is one the best bios out there, soon to surpass what BPTH did
👍️0
whytestocks whytestocks 6 년 전
News: $ORPN Bioblast Announces Effectiveness of Eight to One Reverse Split

Tel Aviv, Israel, March 06, 2019 (GLOBE NEWSWIRE) -- Bioblast Pharma Ltd. (NasdaqCM: ORPN), a clinical-stage, orphan disease-focused biotechnology company, announced the effectiveness of an eight to one reverse split of its share capital. As previously reported, the reverse split was approv...

Find out more https://marketwirenews.com/news-releases/bioblast-announces-effectiveness-of-eight-to-one-reverse-split-7810132.html
👍️0
ClayTrader ClayTrader 6 년 전
* * $ORPN Video Chart 02-19-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
ClayTrader ClayTrader 6 년 전
* * $ORPN Video Chart 11-20-18 * *

Link to Video - click here to watch the technical chart video

👍️0
r1aviator r1aviator 6 년 전
$ORPN

Bioblast Pharma Ltd. Announces Entry Into Merger Agreement to Acquire Enlivex Therapeutics Ltd. to Advance Clinical Stage Immunotherapeutic Drug Pipeline for the Treatment of Life-Threatening Diseases Sepsis, GvHD and Solid Tumors

https://twitter.com/birdseyepix/status/1064655592529117184?s=21
👍️0
r1aviator r1aviator 6 년 전
Running :)

$ORPN
👍️0
r1aviator r1aviator 6 년 전
Took a starter

$ORPN
👍️0
ClayTrader ClayTrader 7 년 전
* * $AXXA Video Chart 05-18-18 * *

Link to Video - click here to watch the technical chart video

👍️0
ClayTrader ClayTrader 7 년 전
* * $SDRL Video Chart 05-18-18 * *

Link to Video - click here to watch the technical chart video

👍️0
ClayTrader ClayTrader 7 년 전
* * $ORPN Video Chart 05-18-18 * *

Link to Video - click here to watch the technical chart video

👍️0
europtiger europtiger 7 년 전
Crazy downer but buying more 3,10 as i belive Shorts will bien there Fingers
👍️0
europtiger europtiger 7 년 전
Looking good

Nice bids coming in

👍️0
crudeoil24 crudeoil24 7 년 전
Very nice call! Blast off > Blast Pharma! orpn
👍️0
europtiger europtiger 7 년 전
Here we Go
👍️0
europtiger europtiger 7 년 전
Yep float has been traded allready

Hope for breakout just bought more

But stop is in
👍️0
crudeoil24 crudeoil24 7 년 전
Traders running this low floater > Brooklyn!
👍️0
europtiger europtiger 7 년 전
Got 2,90‘s
👍️0
Golden Cross Golden Cross 7 년 전
ORPN cheat sheet:

https://www.barchart.com/stocks/quotes/ORPN/cheat-sheet
👍️0
Golden Cross Golden Cross 7 년 전
Short squeeze info:


http://shortsqueeze.com/?symbol=orpn&submit=Short+Quote%E2%84%A2
👍️0
Golden Cross Golden Cross 7 년 전
MACD looking bullish
👍️0
Golden Cross Golden Cross 7 년 전
Chart shaping up:

👍️0
DewDiligence DewDiligence 7 년 전
Caveat emptor! This looks like a financing deal is coming soon.
👍️0
europtiger europtiger 7 년 전
Running hard

Super Low Float
👍️0
Me stocks Me stocks 7 년 전
This one is investment. It will go to 15$ at least in 2018.
👍️0
Awl416 Awl416 7 년 전
That was fast
👍️0
DewDiligence DewDiligence 7 년 전
ORPN 9/30/17 cash=$4.1M (down from $5.2M at 6/30/17):

https://finance.yahoo.com/news/bioblast-pharma-reports-third-quarter-113000168.html
👍️0
DewDiligence DewDiligence 8 년 전
1:5 reverse split is effective today (eom).
👍️0
DewDiligence DewDiligence 8 년 전
ORPN implements 1:5 reverse split effective on date to be announced:

https://www.sec.gov/Archives/edgar/data/1596812/000114420417048497/v475345_6k.htm
👍️0
jcbaby jcbaby 8 년 전
you are correct this play could rise very very fast
👍️0
theprofit444 theprofit444 8 년 전
its a revised outlook lmaooooo
👍️0
jcbaby jcbaby 8 년 전
didn't you say 10 awhile back lol lets hope for anything but its current price
👍️0
theprofit444 theprofit444 8 년 전
itll be 4 dollars a share by yr end
👍️0
DewDiligence DewDiligence 8 년 전
ORPN 2Q17 PR:

https://www.sec.gov/Archives/edgar/data/1596812/000114420417040598/v472433_ex99-1.htm

6/30/17 cash was $5.2M.
👍️0
jcbaby jcbaby 8 년 전
this could rocket over a dollar in a swift blow got to be ready
👍️0
DewDiligence DewDiligence 8 년 전
Two months has elapsed since the post I'm replying to. They'd better come up with a plan soon.
👍️0
stocktrademan stocktrademan 8 년 전
ORPN buy 0.656

inverted head and shoulders bottom
bullish divergence breakout and initial pullback level
high volume on advances, lower volume on retracements indicates strong demand for the stock
pennant breakout soon
breaking out over the ichimoku cloud
moving average golden cross pattern









normal chart




log chart



👍️0

최근 히스토리

NASDAQ
ENLV
Enlivex Therapeutics
LSE
PJ81
Snb Fund 29
TG
AKU1
Akzo Nobel NV
COIN
AURYUST
Aurory
BOV
AGXY9
Agrogalaxy Participacoes ON
Delayed Upgrade Clock
ADVFN Logo
대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지